LifeMD announces integration with LillyDirect pharmacy provider

LifeMD (LFMD) announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of Lilly’s prescription obesity treatment Zepbound to eligible LifeMD patients. Integration with the LillyDirect self-pay pharmacy channel will provide a seamless solution to a patient’s Zepbound fulfillment journey while continuing to offer more accessible pricing and direct shipment to patients. LifeMD’s weight management offering provides a turnkey solution for patients seeking clinical care to lose weight and to reach their healthcare objectives. With Lilly’s recent launch of additional doses of Zepbound vials and reduced pricing of existing vial doses, the integration will provide LifeMD’s eligible on-label patients with streamlined access to this treatment, if prescribed. Zepbound is the first and only FDA-approved dual glucagon-like peptide-1 receptor agonist and glucose-dependent insulinotropic polypeptide obesity medication.